GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 172 filers reported holding GW PHARMACEUTICALS PLC in Q2 2017. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $15,569,000 | +21.1% | 71,779 | -35.6% | 0.00% | +33.3% |
| Q4 2020 | $12,857,000 | +19.3% | 111,403 | +0.6% | 0.00% | 0.0% |
| Q3 2020 | $10,780,000 | -10.6% | 110,724 | +12.7% | 0.00% | -25.0% |
| Q2 2020 | $12,055,000 | +55.4% | 98,229 | +10.9% | 0.00% | +33.3% |
| Q1 2020 | $7,759,000 | -37.4% | 88,601 | -37.4% | 0.00% | 0.0% |
| Q4 2019 | $12,398,000 | +2.8% | 141,476 | +9.0% | 0.00% | 0.0% |
| Q3 2019 | $12,056,000 | -72.9% | 129,777 | -55.2% | 0.00% | -76.9% |
| Q2 2019 | $44,559,000 | +10.0% | 289,410 | +20.4% | 0.01% | +8.3% |
| Q1 2019 | $40,526,000 | +44.1% | 240,402 | -16.7% | 0.01% | +33.3% |
| Q4 2018 | $28,122,000 | -47.0% | 288,758 | -6.9% | 0.01% | -40.0% |
| Q3 2018 | $53,081,000 | +38.7% | 310,078 | +8.0% | 0.02% | +36.4% |
| Q2 2018 | $38,283,000 | +1064.3% | 287,156 | +884.4% | 0.01% | +1000.0% |
| Q1 2018 | $3,288,000 | +3.0% | 29,172 | +20.6% | 0.00% | 0.0% |
| Q4 2017 | $3,192,000 | +60.2% | 24,185 | +23.2% | 0.00% | 0.0% |
| Q3 2017 | $1,992,000 | +42.4% | 19,636 | +40.6% | 0.00% | – |
| Q2 2017 | $1,399,000 | +0.9% | 13,962 | +21.8% | 0.00% | – |
| Q1 2017 | $1,386,000 | +19.3% | 11,462 | +10.2% | 0.00% | – |
| Q4 2016 | $1,162,000 | -10.3% | 10,399 | +6.6% | 0.00% | – |
| Q3 2016 | $1,295,000 | +129.2% | 9,758 | +58.2% | 0.00% | – |
| Q2 2016 | $565,000 | +16.7% | 6,169 | -8.1% | 0.00% | – |
| Q1 2016 | $484,000 | -11.8% | 6,710 | -15.0% | 0.00% | – |
| Q4 2015 | $549,000 | -98.0% | 7,893 | -97.4% | 0.00% | -100.0% |
| Q3 2015 | $27,367,000 | -25.1% | 299,524 | +0.8% | 0.01% | -21.4% |
| Q2 2015 | $36,514,000 | -34.6% | 297,255 | -51.5% | 0.01% | +27.3% |
| Q1 2015 | $55,874,000 | +161.1% | 613,148 | +93.9% | 0.01% | +37.5% |
| Q4 2014 | $21,403,000 | -20.0% | 316,219 | -4.5% | 0.01% | -27.3% |
| Q3 2014 | $26,763,000 | -25.6% | 331,027 | -1.3% | 0.01% | -26.7% |
| Q2 2014 | $35,986,000 | +87.6% | 335,412 | +3.8% | 0.02% | +87.5% |
| Q1 2014 | $19,179,000 | +159725.0% | 323,040 | +107580.0% | 0.01% | – |
| Q4 2013 | $12,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |